Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05893979 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Myopia Control Spectacle Lens Cessation Study

Study acronym: BIRCH
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Jul 31, 2026 to Jul 31, 2027
    v5
  2. Primary completion date: Jan 31, 2025 to Dec 31, 2025
    • Study completion date: Mar 31, 2026 to Jul 31, 2026
    v4
  3. Primary completion date: Dec 31, 2024 to Jan 31, 2025
    • Study completion date: Jan 31, 2025 to Mar 31, 2026
    v3
  4. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 9 to 8
    • Start date changed from estimate of Jun 30, 2023 to Jun 23, 2023
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.
Trial Details
NCT Number NCT05893979
Lead Sponsor SightGlass Vision, Inc.
Conditions
(from sponsor)		 Myopia, Myopia Progression, Juvenile Myopia
Related terms Myopia
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov